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ABSTRACT 
Objective: The main objective of this study was to evaluate the antidiarrheal activity of Bunim bulbocastanum seeds extracts, to exploit the 
medicinal use of plant in the traditional system of medicine scientifically. 
Methods: The adult Wistar albino rats were divided in four groups, i.e. Group M1 (control group) receiving normal saline, group M2 (test group 1) 
receiving the 250 mg/kg Bunium bulbocastanum extract, group M2 (test group 2) receiving the 500 mg/kg Bunium bulbocastanum extract and group 
M4 (reference) receiving 3 mg/kg P. O Loperamide. Each group of mice with a bodyweight of 1 ml/100 g received castor oil. Mice were sacrificed 
and the distance traveled by the charcoal meal and the total length of the intestine was then measured. The peristaltic index and percentage of 
inhibition were calculated by using the formula. 
Results: It was found that in the castor oil-induced intestinal transit method extract produced a significant (p<0.0001) dose-dependent reduction in 
the distance traveled by charcoal meal comparable to the control peak effect was at the dose of 500 mg/kg (PI=12.06±3.38). Likewise, in the 
diarrheal dropping test, Bunium bulbocastanum extract causes a significant (p<0.05) dose-dependent reduction in the number of wet feces i.e. the 
mean wet of feces was decreased from 2.3±0.44 gm to 1.28±0.36 gm i.e. significantly different from that elicited by control (0.80±0.17 gm) 
(p=0.0081). However, there were no significant differences in inhibition at a dose of 250 mg/kg of extract.  
Conclusion: This study demonstrated that the crude methanol extract from B. bulbocastanum seeds possesses significant antidiarrheal property 
and the presence of various secondary metabolites. This justified the antidiarrheal use of plant in the traditional system of medicine. 
Keywords: B. bulbocastanum, Phytochemical screening, Anti-diarrheal activity, Methanol extract 
© 2021 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/) 
DOI: https://dx.doi.org/10.22159/ijpps.2021v13i6.40035. Journal homepage: https://innovareacademics.in/journals/index.php/ijpps.  
 
INTRODUCTION 
Diarrhea is an alteration of normal bowel movement characterized by an 
increase in the volume, fluidity, frequency and passage of loose stool at 
least three times a day. It is a common symptom of gastrointestinal 
infection due to the number of communicable factors [1, 2]. 
According to the WHO 3-5 billion cases of diarrhea are reported 
annually, of which 1 billion are less than 5 y. As a results, it accounts 
for 20% of infant mortality [3, 4]. Especially in developing countries 
like Nepal, it is an important health problem. So every year Nepal 
faces an outbreak due to the number of poor health hygiene factors. 
In year 2000, almost 67,000 people were affected, 371 of whom, 
died of diarrheal disease. Likewise, in the year 2014, total death 
from diarrheal disease was 3.89% [5]. Beside this reality in Nepal, 
384 number of species are used to treat diarrhea [6, 7]. 
Lots of modern technology has been established for the synthesis of 
new molecules, despite the fact that a number of developing 
countries still use the herbal-based crude drug for diarrheal 
treatment [8]. Bunium bulbocastanum is one of the important 
medicinal plants that grows in mountainous to shurland of Iran, 
Pakistan, India, Nepal and Afghanistan [9, 10]. It is an herbaceous 
perennial plant with typical habitat, i.e. Grows in chalky and rough 
grassland in arrange of soil from light (sandy), medium (loamy) to 
heavy (clay) soil [10]. In the indigenous system of medicine seed of 
B. bulbocastanum is regarded as a stimulant and carminative and 
found to be useful in diarrhea and dyspepsia as well as essential oil 
fraction of the seed is used in perfumery as a carminative purpose. 
Seed propagation and germination ratio is very low because of long 
seed cycles [2, 4]. Its plants vary from dwarf (30 cm) to tall (80 cm), 
compact or spreading, moderately to highly branch tuberous. It is a 
perennial herb, the leaves are freely pinnate, finely dissected and 
filiform. Flowers are small and white in color [11, 12]. 
B. bulbocstanum traditionally used in the treatment of diarrhea from 
past decades. So the main aim of the study was to provide scientific 
justification for the use of Bunium bulbocastanum in modern medicine. 
MATERIALS AND METHODS 
Collection and identification of plant material 
The fresh seed of Bunium bulbocastanum 1000 gm was collected in 
September 2016 from the local market of Bhairahawa and the 
sample was identified in the Institute of Agricultural and Animal 
Sciences Paklihawa, Rupandehi, Nepal with a plant identification 
number (PKH3077). 
Preparation of plant material 
The collected seeds were separated from undesirable material. The 
whole seeds were kept in the shade for drying for three days. After 
drying, the seed was grounded into powder using an electronic 
grinder and the final grinded powder was weight. 
Chemical and reagent  
Methanol, Ethanol, distilled water, Sulphuric acid, Ferric chloride, 
Potassium hydroxide, Benzene, Lead acetate Glacial acetic acid, 
Picric acid, Activated charcoal, Loperamide, Castor oil, Ketamine 
Diethyl ether, Normal saline, Gum acacia, Sodium hydroxide. 
Preparation of plant extract 
The seeds were extracted by maceration. The grinded fruits powder 
(950 gm) was soaked in methanol for 10 d in a 2000 ml conical flask 
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i.e. 240-250 gm in each flask with 650 ml of methanol in each and 
mouth of the flask was covered with the aluminum foil. After 10 d, 
the mixture was filtered, then the filtrate was combined and then 
concentrated with a rotary evaporator at 40 °C. A black-green 
methanol extract of B. bulbocastanum obtained after concentration. 
Phytochemical screening 
A known volume of the sample of B. bulbocastanum was screened for 
the presence of some secondary metabolites as described for 
carbohydrates, alkaloids, Steroids, anthraquinones, cardenolides and 
dienolides, saponin, phenolic compound, flavonoids [13], cardiac 
glycosides, tannins and triterpenes [14]. 
Animals 
Wistar albino mice of 73-159 gm of either sex obtained from 
Banaspati Bibhag, Kathmandu, were used. They were kept in a 
standardized environmental condition (22±2.5 °C), humidity 85%, 
12 h light and 12 h dark cycle and feeded with a standard rodent diet 
and water. Approval for the use of animals in the study was obtained 
from the Institute Review Committee of Universal College of Medical 
Science, Bhairahawa (IRC NO: UCMS/IRC/106/15). 
Sample preparation 
Appropriate weight of the extract was taken and the required 
concentration was made during the experimental process to make 
the standard solution of concentration 500 mg/ml and 500 mg/2 ml. 
Preparation of standard 
Loperamide standard solution was made by dissolving the 
appropriate amount of the drug. 
Preparation of activated charcoal solution 
Firstly 10 gm of activated charcoal was weight likewise 5 gm of gum 
acacia was also weighed. Afterward, the weighed amount of the gum 
acacia was transferred into the 100 ml volumetric flask and some 
amount of water was added to the flask to dissolve the gum acacia. 
And 10 gm of activated charcoal was added to the gum acacia 
solution and the volume was made up to 100 ml.  
Castor oil-induced intestinal transit 
Wistar albino rats were divided into four groups in such a way that 4 
in each group, contained a total 16 of rats. All animal was fasted for 
24 h prior to the experiment. Group M1 received distilled water 10 
mg/kg P. O, group M2 and M3 were treated with B. bulbocastanum 
extract 250 mg/kg and 500 mg/kg P. O BBME respectively, whereas 
group M4 were treated with reference drug loperamide 3 mg/kg P. 
O. After 40 min castor oil was administered to each mouse by oral 
administration of a dose of 1 ml/100g body weight to each mouse. 
After 30 min of administration of castor oil, charcoal meal (10% 
activated charcoal in 5% gum acacia) 1 ml/100 gm body weight was 
administered to each animal. Then after 30 min each mouse was 
sacrificed and the abdominal cavity was dissected and entire small 
intestine was isolated and the distance travelled by the charcoal meal 
from the pylorus to the ileocecal junction was measured. The length of 
the entire small intestine was also measured. The peristaltic index of 




Where PI= peristaltic index Lm= length of charcoal meal  




Castor oil-induced diarrheal drooping test 
Wistar albino rats were divided into four groups in such a way that 4 
in each group contained a total 16 of rats. All animals had been 
fasted for 24 h prior to the experiment. Group M1 received distilled 
water 10 mg/kg P. O, group M2 and M3 were treated with B. 
bulbocastanum extract 250 mg/kg and 500 mg/kg P. O BBME 
respectively, whereas group M4 were treated with reference drug 
loperamide 3 mg/kg P. O. Each animal was placed in an individual 
cage and the floor of the cage was lined with blotting paper and 
diarrheal drooping was observed for 4 h. The initial weight and final 
weight of the filter paper were taken and the mean weight of the 
feces was calculated and evaluated by subtracting the final weight of 
filter paper and initial weight of filter paper [16]. 
RESULTS 
Phytochemical screening 
The analysis of B. Bulbocastanum revealed the presence of tannins, 
carbohydrates, cardiac glycosides, flavonoids and phenol, while 
anthraquinones, triterpenes, cardinolide and dienolide were not 
detected. These observations are summarized in table 1 below. 
 
Table 1: Secondary metabolites of Bunium bulbocastanum seeds 
Secondary metabolite Observation Inference 
Alkaloids Cream color with Mayer’s reagent Reddish-brown precipitate with Wagner’s and Dragendorffs reagent. Not detected 
Carbohydrate Presence of violet ring at the junction Present 
Tannins White precipitate with ethanolic KOH Present 
Saponins Stable, persistent froth with water Present 
Flavonoids Dark yellow color with KOH Present 
Phenolics Greenish precipitate with FeCl3. Present 
Steroids Red color with drops of concentrated H2SO4. Not detected 
Cardiac glycosides Presence of reddish-brown color at the interface Present 
Anthraquinones Absence of pink in the ammonical phase. Not detected 
Cardenolides and dienolides Absence of brown ring at the interface. Not detected 
 
Castor oil-induced intestinal transit 
The study from castor oil-induced intestinal transit revealed that the 
methanol seed extract of Bunium bulbocastanum (250 mg/kg and 500 
mg/kg) produced a significant (p<0.0001) dose-dependent reduction 
in the distance travelled by charcoal meal compared to the control. 
The peak anti-motility effect occurred at a dose of 500 mg/kg 
(PI=12.06±3.38). This effect was comparable to that produced by 
standard antidiarrheal drug loperamide (PI=1.34±1.64). 
  
Table 2: Peristaltic index of the different rat treated with control, loperamide, 250 mg/kg and 500 mg/kg of extract 
Group Castor 
oil  
Treatment Distance led by charcoal (cm) Total length of small intestine Peristaltic index P-value 
(ANOVA) 
I + Distilled Water 30.28±4.78 63.63±6.62 43.43±5.9 ˗ 
II + Loperamide 0.88±1.06 65±8.03 1.34±1.64** 0.000092 
III + 250 mg/kg 21.25±2.90 65.08±5.28 32.81±5.4** 0.000024 
IV + 500 mg/kg 7.38±1.45 62.28±9.05 12.06±3.38** 0.00051 
**Indicates the p-value less than 0.0001as compared to the control group, i.e. highly significant 
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Table 3: Mean weight of feces during 4 h of treatment and percentage inhibition of defecation of the different treatment group of rats 
Group Castor oil Treatment Meanwt. of feces during 4 h of treatment Percentage inhibition P-value (ANOVA) 
I + DW 2.34±0.44 ˍ ˍ 
II + Loperamide 0.8±0.17* 62.88 0.000656 
III + 250 mg/kg 2.23±0.20 4.58 0.562 
IV + 500 mg/kg 1.28±0.36* 45.23 0.0081 
*Indicates the p value less than 0.05 as compared to control i.e. highly significant. 
 
Diarrheal drooping test 
During 4 h after administration of castor oil, all the rats in the 
control group (distilled water 10 ml/kg P. O) produced copious 
diarrhea. Pretreatment of rats with the methanol seed extract of 
Bunium bulbocastanum causes a significant (p<0.05) dose-
dependent reduction in the amount of wet feces. The reduction 
exhibit of 500 mg/kg was higher than the next dose of 250 mg/kg. 
At the dose of 500 mg, the mean weight of feces decreased from 
2.3±0.44 gm (as observed in control group) to 1.28±0.36 gm which 
is significantly different from that elicited by control (0.80±0.17 gm), 
(p = 0.0081). However, there was no significant difference in 
diarrhea inhibition per 250 mg/kg of extract. 
The highest percentage inhibition of 45.23% was obtained with the 
dose of 500 mg/kg body weight of extract which was comparable to 
62.88% produced by loperamide (table 3). 
DISCUSSION 
With effective ethnopharmacological value, B. Bulbocastanum is 
widely used by different tribes as an effective herbal medicine. 
Literature surveys have revealed that leaves of B. Bulbocastanum are 
being used for diseases like diarrhea [17]. The study aimed to 
examine the antidiarrheal effect of B. Bulbocastanum, to ascertain 
scientific rationales behind its ethnical practice. Our study validates 
the efficacy of methanol extract of B. Bulbocastanum on the castor 
oil-induced gastrointestinal transit model. These useful biological 
activities may be attributed by the presence of bioactive compounds 
like tannins, flavonoids, alkaloids, glycosides, phenols, steroids, 
saponins and terpenoids as reported on phytochemical screening. 
A lethal dose (LD 50) of the plant extract could not be acquired, as no 
mortality was detected up to the maximum dose 4000 mg/kg and the 
extract was found to be safe with a wide therapeutic range. Therefore, 
two comparative doses of 250 mg/kg and 500 mg/kg were used in in 
vivo study reported by previous acute toxicity study [17]. 
Diarrhea results from an imbalance of the absorptive and secretory 
mechanism within the bowl. In absorptive/osmotic diarrhea a large 
number of osmotic particles on the gut wall compared with 
absorptive capacity, whereas in secretory diarrhea, excessive 
secretion mucosal fluid [18, 19]. Some studies indicate that in 
watery diarrhea mortality was mentioned as a major contributing 
factor i.e. rapid intestinal transit reduces the contact time between 
absorptive solute and normal epithelium, as well as other 
contributing factor like 5-HT present in the gut stimulate intestinal 
motility, secretion and vasodilatation promote for development of 
diarrhea [20]. In our experiment, extract produced a significant 
dose-dependent reduction in the amount of wet feces in castor oil-
induced intestinal transit test and diarrheal drooping test. Most of 
the articles mention that ricinolic acid, an active component of 
castor oil, is responsible for inducing permeability changes in the 
mucosal membrane and alteration of ion [4, 21, 22]. Besides these 
purposed mechanisms, castor oil inhibits the intestinal Na+and 
K+ATPase activity and stimulates the release of Nitric Oxide (NO) 
hereby NO causes the release of prostaglandin like PGE2 that are 
responsible for hypersecretory action [4, 15, 23, 24]. Thus the 
extract could have been shown an antidiarrheal activity by reducing 
intestinal permeability or by minimizing hypersecretion.  
In the animal experiment, Loperamide was used as a reference drug 
and sample extract had a statistically comparable effect to the 
reference drug. It has been reported that loperamide increases the 
intestinal absorption rate by epithelial cell and also increase 
intestinal transit time by the slowdown of intestinal motility. 
Similarly, in animal model experiment it was found that loperamide 
inhibits the intestinal secretion induced by E. Coli, and Cholera toxin 
[25]. Beside this loperamide is an opiate analog, the drug shows its 
mechanism of action by decreasing the gout muscle tone, decrease 
the PGE2 mediated fluid secretion, slow down transit time and 
increase the colonic water absorption [26, 27]. 
When the sample is phytochemically tested, the extract reveals the 
presence of phytochemical compounds like tannins and flavonoids. 
Some of the previous study mentions the antidiarrheal activity of 
Phyto-constituents like tannins and flavonoid [28, 29]. In terms of 
flavonoid, they may act by inhibition of intestinal motility and 
hydroelectric secretion to slow down the diarrheal effect [28]. 
Likewise, tannins is well known for its astringent property, hereby it 
may cause precipitation of intestinal protein on the intestinal lining 
as a resultant effect form a protective layer over it with inhibition of 
toxin from abdomen, which are responsible for diarrheal effect [28, 
30]. So this result suggests that these phytochemicals may have 
contributed to antidiarrheal activity. 
CONCLUSION 
The methanol extract of B. bulbocastanum seeds showed 
antidiarrheal activity in several models of diarrheal conditions in 
test animals. The obtained result thus provided the experimental 
basis for understanding the use of B. bulbocastanum in traditional 
medicine as an antidiarrheal agent. Phytochemical screening 
revealed the presence of various secondary metabolites such as 
tannins, glycosides, flavonoids and carbohydrates in the seeds of 
experimental plants. 
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